Beijing Tiantan Biological Products Corp Ltd (600161) — Capital Reinvestment Ratio
Beijing Tiantan Biological Products Corp Ltd (600161) has a Capital Reinvestment Ratio of 0.39x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥318.80 Million) in capital expenditures (CN¥125.07 Million). See 600161 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Tiantan Biological Products Corp Ltd Capital Reinvestment Ratio (1998–2024)
This chart tracks Beijing Tiantan Biological Products Corp Ltd's Capital Reinvestment Ratio across 27 annual periods.
Annual Capital Reinvestment Ratio for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year Capital Reinvestment Ratio for Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. For live market cap and broader valuation context, see market value of Beijing Tiantan Biological Products Corp.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.30x | CN¥819.78 Million | CN¥1.07 Billion | ▲ +189.2% |
| 2023 | 0.45x | CN¥2.39 Billion | CN¥1.08 Billion | ▼ -62.6% |
| 2022 | 1.20x | CN¥1.13 Billion | CN¥1.35 Billion | ▲ +4.2% |
| 2021 | 1.15x | CN¥980.35 Million | CN¥1.13 Billion | ▲ +33.1% |
| 2020 | 0.87x | CN¥702.11 Million | CN¥608.91 Million | ▲ +5.9% |
| 2019 | 0.82x | CN¥642.47 Million | CN¥526.23 Million | ▲ +88.9% |
| 2018 | 0.43x | CN¥677.92 Million | CN¥293.90 Million | ▼ -34.6% |
| 2017 | 0.66x | CN¥218.39 Million | CN¥144.87 Million | ▲ +35.7% |
| 2016 | 0.49x | CN¥428.37 Million | CN¥209.39 Million | ▼ -23.0% |
| 2015 | 0.64x | CN¥473.26 Million | CN¥300.57 Million | ▼ -34.6% |
| 2014 | 0.97x | CN¥477.95 Million | CN¥464.16 Million | ▲ +0.3% |
| 2013 | 0.97x | CN¥566.43 Million | CN¥548.37 Million | ▼ -25.0% |
| 2012 | 1.29x | CN¥432.00 Million | CN¥557.87 Million | ▼ -36.5% |
| 2011 | 2.04x | CN¥353.15 Million | CN¥718.67 Million | ▲ +26.4% |
| 2010 | 1.61x | CN¥184.85 Million | CN¥297.54 Million | ▲ +277.4% |
| 2009 | 0.43x | CN¥448.23 Million | CN¥191.17 Million | ▼ -21.6% |
| 2008 | 0.54x | CN¥276.39 Million | CN¥150.31 Million | ▲ +25.8% |
| 2007 | 0.43x | CN¥153.55 Million | CN¥66.40 Million | ▼ -6.6% |
| 2006 | 0.46x | CN¥154.36 Million | CN¥71.50 Million | ▲ +53.3% |
| 2005 | 0.30x | CN¥131.69 Million | CN¥39.78 Million | ▼ -61.3% |
| 2004 | 0.78x | CN¥110.11 Million | CN¥85.89 Million | ▼ -45.5% |
| 2003 | 1.43x | CN¥62.93 Million | CN¥90.02 Million | ▲ +246.6% |
| 2002 | 0.41x | CN¥84.38 Million | CN¥34.83 Million | ▼ -60.9% |
| 2001 | 1.06x | CN¥46.49 Million | CN¥49.09 Million | ▲ +14.9% |
| 2000 | 0.92x | CN¥47.90 Million | CN¥44.04 Million | ▼ -9.7% |
| 1999 | 1.02x | CN¥42.58 Million | CN¥43.34 Million | ▼ -58.1% |
| 1998 | 2.43x | CN¥23.71 Million | CN¥57.61 Million | — |